Technically, just FDA acceptance of the BLA - without priority review granted, would still constitute insider knowledge and preclude share purchase. The simple answer is, no one but the FDA is across the decision. High probability remains of acceptance with priority review
Technically, just FDA acceptance of the BLA - without priority...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.000(0.00%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.09 | $918.5K | 834.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 34577 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 12789 | 10 |
View Market Depth
| Last trade - 11.14am 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |